Profile data is unavailable for this security.
About the company
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.
- Revenue in USD (TTM)811.40m
- Net income in USD-80.80m
- Incorporated2018
- Employees3.00k
- LocationMirion Technologies Inc1218 Menlo DriveATLANTA 30318United StatesUSA
- Phone+1 (770) 432-2744
- Fax+1 (302) 636-5454
- Websitehttps://www.mirion.com/
Mergers & acquisitions
Acquired company | MIR:NYQ since announced | Transaction value |
---|---|---|
Ec2 Software Solutions LLC | 44.01% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mesa Laboratories Inc | 212.87m | 948.00k | 623.01m | 698.00 | 659.47 | 1.55 | 17.66 | 2.93 | 0.1751 | 0.1751 | 39.54 | 74.70 | 0.3031 | 2.38 | 5.43 | 304,977.10 | 0.135 | 0.6535 | 0.1438 | 0.7029 | 61.02 | 60.10 | 0.4453 | 1.97 | 1.86 | 0.2604 | 0.3663 | 100.96 | 18.85 | 17.90 | -50.29 | -- | 10.18 | 0.00 |
Quanterix Corp | 122.37m | -32.33m | 650.97m | 441.00 | -- | 1.86 | -- | 5.32 | -0.8587 | -0.8587 | 3.26 | 9.13 | 0.2848 | 2.64 | 5.51 | 277,478.50 | -7.53 | -15.96 | -8.19 | -17.66 | 57.73 | 52.79 | -26.42 | -53.79 | 9.26 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
Standard Biotools Inc | 106.34m | -74.66m | 950.94m | 534.00 | -- | -- | -- | 8.94 | -0.9437 | -0.9437 | 1.34 | 2.03 | 0.2981 | 2.66 | 5.76 | 199,138.60 | -20.93 | -28.17 | -26.63 | -33.60 | 47.44 | 51.58 | -70.21 | -74.85 | 1.26 | -13.80 | 0.2801 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
CTS Corp | 530.18m | 53.31m | 1.52bn | 4.08k | 29.18 | 2.92 | 18.47 | 2.87 | 1.70 | 1.70 | 16.91 | 17.01 | 0.7165 | 5.71 | 5.94 | 129,913.80 | 7.20 | 4.48 | 8.34 | 5.33 | 34.76 | 34.71 | 10.05 | 5.86 | 2.71 | -- | 0.1146 | 17.23 | -6.21 | 3.19 | 1.61 | 5.56 | -12.35 | 0.00 |
Mirion Technologies Inc | 811.40m | -80.80m | 2.26bn | 3.00k | -- | 1.55 | 29.01 | 2.79 | -0.4053 | -0.4053 | 4.07 | 6.45 | 0.3014 | 2.94 | 3.79 | 270,466.70 | -3.06 | -- | -3.44 | -- | 44.91 | -- | -10.14 | -- | 1.57 | -0.088 | 0.3111 | -- | 11.58 | -- | 65.01 | -- | -- | -- |
Integra Lifesciences Holdings Corp | 1.54bn | 67.74m | 2.27bn | 3.95k | 34.21 | 1.42 | 11.87 | 1.47 | 0.8444 | 0.8444 | 19.19 | 20.31 | 0.4019 | 1.59 | 5.79 | 390,667.30 | 1.77 | 3.33 | 1.92 | 3.68 | 63.09 | 63.67 | 4.39 | 7.99 | 2.18 | 7.95 | 0.4857 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
OSI Systems, Inc. | 1.47bn | 125.86m | 2.31bn | 6.24k | 18.66 | 2.84 | 13.92 | 1.57 | 7.26 | 7.26 | 84.94 | 47.71 | 0.8869 | 2.33 | 3.65 | 235,419.00 | 7.59 | 6.23 | 12.57 | 9.18 | 35.32 | 35.69 | 8.56 | 7.07 | 0.8881 | 7.45 | 0.3752 | 0.00 | 8.04 | 3.25 | -20.43 | 47.89 | -6.71 | -- |
Olink Holding AB (publ) - ADR | 169.60m | -31.60m | 2.86bn | 707.00 | -- | -- | -- | 16.87 | -0.2547 | -0.2547 | 1.36 | -- | 0.3145 | 0.9963 | 2.94 | 239,882.60 | -5.86 | -- | -6.40 | -- | 67.49 | -- | -18.63 | -- | 3.55 | -- | 0.0506 | -- | 21.27 | -- | -145.90 | -- | -- | -- |
Badger Meter Inc | 740.77m | 102.31m | 5.56bn | 2.14k | 54.45 | 10.37 | 42.25 | 7.50 | 3.47 | 3.47 | 25.13 | 18.22 | 1.08 | 3.07 | 8.39 | 346,154.70 | 14.86 | 12.26 | 18.17 | 14.60 | 39.26 | 39.38 | 13.81 | 12.06 | 2.30 | -- | 0.00 | 36.36 | 24.40 | 10.16 | 39.25 | 27.22 | 6.79 | 12.07 |
Vontier Corp | 3.07bn | 430.90m | 6.10bn | 8.00k | 14.26 | 6.19 | 10.97 | 1.98 | 2.77 | 2.77 | 19.73 | 6.37 | 0.7163 | 5.03 | 6.21 | 384,325.00 | 10.04 | 10.80 | 12.63 | 14.04 | 47.17 | 44.62 | 14.01 | 13.36 | 1.23 | 6.23 | 0.6935 | 2.24 | -2.80 | 3.03 | -6.08 | -0.5018 | 7.23 | -- |
Cognex Corp | 847.22m | 99.64m | 7.52bn | 2.99k | 76.18 | 5.05 | 60.34 | 8.88 | 0.5749 | 0.5749 | 4.90 | 8.68 | 0.425 | 1.66 | 5.72 | 283,161.80 | 5.00 | 10.63 | 5.56 | 11.56 | 70.75 | 72.97 | 11.76 | 22.38 | 2.61 | -- | 0.00 | 57.03 | -16.75 | 0.7624 | -47.46 | -13.24 | -9.06 | 9.03 |
MKS Instruments Inc | 3.62bn | -1.84bn | 8.18bn | 10.00k | -- | 3.30 | -- | 2.26 | -27.56 | -27.56 | 54.17 | 36.95 | 0.3513 | 2.01 | 5.19 | 362,100.00 | -17.86 | -1.60 | -19.57 | -1.75 | 45.35 | 44.95 | -50.84 | -3.25 | 2.01 | 1.16 | 0.6596 | -- | 2.11 | 11.78 | -652.85 | -- | 6.69 | 2.44 |
Bio Rad Laboratories Inc | 2.67bn | -637.32m | 9.41bn | 8.03k | -- | 0.913 | -- | 3.52 | -21.49 | -21.49 | 91.24 | 306.51 | 0.2071 | 1.65 | 5.43 | 332,660.30 | -4.94 | 9.08 | -5.16 | 9.60 | 53.56 | 55.55 | -23.86 | 41.97 | 4.34 | 0.3095 | 0.1207 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 20.86m | 9.54% |
T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 19.87m | 9.09% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2023 | 18.78m | 8.59% |
Goldman Sachs Asset Management LPas of 31 Dec 2023 | 16.03m | 7.33% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 13.55m | 6.20% |
Swedbank Robur Fonder ABas of 29 Feb 2024 | 10.64m | 4.86% |
Janus Henderson Investors US LLCas of 31 Dec 2023 | 9.31m | 4.26% |
Omega Advisors, Inc.as of 31 Dec 2023 | 7.51m | 3.44% |
P2 Capital Partners LLCas of 31 Dec 2023 | 5.85m | 2.67% |
Alyeska Investment Group LPas of 31 Dec 2023 | 5.16m | 2.36% |